NEW YORK (GenomeWeb News) – Precision BioSciences today claimed victory in a lawsuit filed against the company by Cellectis alleging patent infringement.

According to Research Triangle Park, NC-based Precision Bio, a jury in the US District Court for the District of Delaware found all claims of Cellectis' US Patent No. 7,897,372 that were asserted against Precision Bio to be invalid. The jury also found Precision Bio did not "literally" infringe the asserted claims, meaning Precision Bio did not incorporate each and every element of Cellectis' patent in its own technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Researchers report that while host genetics influence the oral microbiome, they don't appear to affect cavity-causing microbes, the Economist says.

Pandas' gut microbiomes change as what they eat changes with the seasons, writes Discover's Inkfish blog.

In PLOS this week: comparative genomic study of malaria-linked macaque parasite, search for apple root reference genes, and more.